Aprotinin - a New Drug Candidate for The Prevention of SARS-CoV-2 (COVID-19)

Andrey A Ivashchenko; Andrey A Svistunov; Tatiana V Khorobryh; Vladimir G Loginov; Ruben N Karapetian; Natalia P Mishchenko; Stanislav V Poyarkov; Maxim V Volgin; Elena V Yakubova; Michael P Topr; Oleg V Pyankov; Anastasia V Magerramova; Alexey A Tomilov; Alexandre V Ivashchenko

Статья

Aprotinin - a New Drug Candidate for The Prevention of SARS-CoV-2 (COVID-19)

Andrey A Ivashchenko, Andrey A Svistunov, Tatiana V Khorobryh, Vladimir G Loginov, Ruben N Karapetian, Natalia P Mishchenko, Stanislav V Poyarkov, Maxim V Volgin, Elena V Yakubova, Michael P Topr, Oleg V Pyankov, Anastasia V Magerramova, Alexey A Tomilov, Alexandre V Ivashchenko,

2020

The efficacy of Aprotinin as prophylactic treatment of Covid-19 was studied in the hamster model of SARS-CoV-2 and in the health care personnel working with Covid-19 patients in hospital. High efficacy of Aprotinin in pre- and post-exposure prophylaxis of SARS-CoV-2 was demonstrated.

Цитирование

Документы

Источник

Версии

1. Version of Record от 2020-09-13

Метаданные

Об авторах

Andrey A Ivashchenko
Andrey A Svistunov
Tatiana V Khorobryh
Vladimir G Loginov
Ruben N Karapetian
Natalia P Mishchenko
Stanislav V Poyarkov
Maxim V Volgin
Elena V Yakubova
Michael P Topr
Oleg V Pyankov
Anastasia V Magerramova
Alexey A Tomilov
Alexandre V Ivashchenko

Тип документа

preprint

Тип лицензии Creative Commons

CC BY

Правовой статус документа

Свободная лицензия

Источник

covid19-preprints.microbe.ru

Поиск по репозиторию

Статья

Aprotinin - a New Drug Candidate for The Prevention of SARS-CoV-2 (COVID-19)

Похожие публикации

Документы

Источник

Версии

Метаданные